newsfilter
← Latest News
GlobeNewswire·

Oragenics Reports Continued Clinical Progress, Provides Regulatory and NYSE American Listing Update

SARASOTA, Fla., Aug. 28, 2026 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE:OGEN), a clinical-stage biopharmaceutical company developing brain-targeted therapeutics through its proprietary intranasal delivery platform,